Current Drug Targets
Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 10 - Number 2
Editorial [Hot Topic: The Fabisch-Symposium 2009 on Targeted Tumor Therapies(Guest Editors: C. Bachran and H. Fuchs)]
, 10(2): 88Christopher Bachran and Hendrik Fuchs
DOI: 10.2174/138945009787354548
Targeted Tumor Therapies at a Glance
, 10(2): 89 - 93H. Fuchs and C. Bachran
DOI: 10.2174/138945009787354557
Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family
, 10(2): 94 - 103E. Bremer, M. de Bruyn, H. Wajant and W. Helfrich
DOI: 10.2174/138945009787354593
Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma
, 10(2): 104 - 109A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville and J. H. Woo
DOI: 10.2174/138945009787354539
Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
, 10(2): 110 - 117B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop
DOI: 10.2174/138945009787354566
Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
, 10(2): 118 - 125U. Elsasser-Beile, P. Buhler and P. Wolf
DOI: 10.2174/138945009787354601
Saponins as Tool for Improved Targeted Tumor Therapies
, 10(2): 140 - 151H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland and C. Bachran
DOI: 10.2174/138945009787354584
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net